Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: successful rechallenge after desensitization
- PMID: 9578315
- DOI: 10.1038/sj.bmt.1701161
Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: successful rechallenge after desensitization
Abstract
Carboplatin hypersensitivity has rarely been reported in patients receiving repeated cycles of therapy, but has not been reported in transplant settings. We report a case of carboplatin hypersensitivity during conditioning for autologous PBSC transplantation. The patient suddenly developed chest tightness, hemoptysis, hypoxia and hypotension, resulting in a transient myocardial ischemia. The pathophysiologic mechanism for the event seemed to be non-immune-mediated direct histamine release given the lack of prior exposure to platinum. Contrary to advice not to continue further treatment with carboplatin by some authors, we successfully desensitized the patient and subsequently gave more carboplatin as a part of conditioning. Awareness of carboplatin as one of the causes of hypersensitivity may help avoid further problems either by substitution or desensitization, along with premedications.
Similar articles
-
[Successful desensitization protocol for patients with hypersensitivity reactions caused by carboplatin].Gan To Kagaku Ryoho. 2010 Apr;37(4):731-3. Gan To Kagaku Ryoho. 2010. PMID: 20414037 Japanese.
-
[Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma].Gan To Kagaku Ryoho. 2007 Sep;34(9):1505-8. Gan To Kagaku Ryoho. 2007. PMID: 17876157 Japanese.
-
Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.Med Pediatr Oncol. 1996 Feb;26(2):105-10. doi: 10.1002/(SICI)1096-911X(199602)26:2<105::AID-MPO7>3.0.CO;2-P. Med Pediatr Oncol. 1996. PMID: 8531847
-
Carboplatin hypersensitivity reactions.Clin J Oncol Nurs. 2006 Oct;10(5):595-8. doi: 10.1188/06.CJON.595-598. Clin J Oncol Nurs. 2006. PMID: 17063613 Review.
-
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12. Cancer Chemother Pharmacol. 2002. PMID: 12042984 Review.
Cited by
-
Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents.Int J Gynecol Cancer. 2022 Aug 1;32(8):1056-1062. doi: 10.1136/ijgc-2022-003466. Int J Gynecol Cancer. 2022. PMID: 35675969 Free PMC article.
-
Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.Met Based Drugs. 2010;2010:207084. doi: 10.1155/2010/207084. Epub 2010 Sep 20. Met Based Drugs. 2010. PMID: 20886011 Free PMC article.
-
Prevention and management of antineoplastic-induced hypersensitivity reactions.Drug Saf. 2001;24(10):767-79. doi: 10.2165/00002018-200124100-00005. Drug Saf. 2001. PMID: 11676304 Review.
-
Readministration of Platinum Agents in Recurrent Ovarian Cancer Patients Who Developed Hypersensitivity Reactions to Carboplatin.In Vivo. 2019 Nov-Dec;33(6):2045-2050. doi: 10.21873/invivo.11702. In Vivo. 2019. PMID: 31662536 Free PMC article.
-
Hypersensitivity to Carboplatin in Children with Malignancy.Front Pharmacol. 2017 Apr 12;8:201. doi: 10.3389/fphar.2017.00201. eCollection 2017. Front Pharmacol. 2017. PMID: 28446876 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical